Spontaneous proliferative lesions in the nasopharyngeal meatus of F344 rats.
Spontaneous proliferative lesions in the nasopharyngeal meatus were identified as the cause of death in 12 of 1,600 male and 5 of 1,600 female Fisher 344 (F344) rats used in 2-yr carcinogenicity studies; none of the lesions were considered treatment related. All the rats showed dyspnea, abdominal distension, and clinical deterioration. Gross features were characterized by simultaneous occurrence of conspicuous gaseous distension of the intestinal tract, especially in the ileum and cecum, and focal nodular lesions in the nasopharyngeal meatus. Histopathologically, the nasopharyngeal meatus was partially obstructed by the following proliferative lesions: 3 areas of hyperplasia of the ectopic sebaceous glands in the soft and hard palate, 4 areas of squamous metaplasia (SM) with massive hyperkeratosis, 5 squamous cell papillomas (SCPs), and 5 squamous cell carcinomas (SCCs). No pathological changes were found in the distended portion of the intestinal tract. Formalin-fixed, paraffin-embedded samples of the proliferative lesions from the nasopharyngeal meatus were examined for the presence of mutations in the c-H-ras and c-K-ras genes. In vitro amplification of DNA using a polymerase chain reaction was combined with a nonisotopic method for selective oligonucleotide hybridization. Two of the 4 SM lesions, 3 of the 5 SCPs, and 5 of the 5 SCCs contained 1-3 point mutations in the c-H-ras and/or c-K-ras gene. Immunohistochemically, overexpression of p53 protein was found in 1 area of SM with a dysplastic lesion and 2 SCCs. These findings indicate that detailed examination of the upper respiratory system, including the nasopharyngeal meatus, may be particularly helpful for identifying primary occult lesions in F344 rats that show only gut distension at necropsy in long-term toxicity studies. In addition, mutations of the ras genes may be an important step in the early stages of carcinogenesis in the rat nasopharyngeal meatus, whereas p53 mutations could occur relatively late.
Hayashi
S
S
Pharmacology Laboratories, Takeda Chemical Industries, Osaka, Japan. hayashi_shinmo@takeda.co.jp
Mori
I
I
Nonoyama
T
T
D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D002828:Choristoma / Q000473:pathology; D005260:Female; D011905:Genes, ras / Q000235:genetics; D006965:Hyperplasia / Q000473:pathology; D007150:Immunohistochemistry; D008297:Male; D008679:Metaplasia / Q000473:pathology; D009302:Nasopharyngeal Diseases / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000662:veterinary; D009303:Nasopharyngeal Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology* / Q000662:veterinary*; D015345:Oligonucleotide Probes; D010212:Papilloma / Q000473:pathology; D017354:Point Mutation; D051381:Rats; D011916:Rats, Inbred F344 / Q000235:genetics; D012376:Rodent Diseases / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D012627:Sebaceous Glands; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D015345:Oligonucleotide Probes; D016159:Tumor Suppressor Protein p53